Heartflow, Inc. Common Stock (HTFL)
US — Healthcare Sector
Automate Your Wheel Strategy on HTFL
With Tiblio's Option Bot, you can configure your own wheel strategy including HTFL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HTFL
- Rev/Share 1.0002
- Book/Share -11.0994
- PB -3.3578
- Debt/Equity -0.2293
- CurrentRatio 3.5955
- ROIC -0.237
- MktCap 3108172647.0
- FreeCF/Share -0.5255
- PFCF -73.3734
- PE -72.3281
- Debt/Assets 1.2873
- DivYield 0
- ROE 0.0466
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HTFL | Canaccord Genuity | -- | Buy | -- | $35 | Sept. 2, 2025 |
| Initiation | HTFL | JP Morgan | -- | Overweight | -- | $36 | Sept. 2, 2025 |
| Initiation | HTFL | Morgan Stanley | -- | Equal Weight | -- | $35 | Sept. 2, 2025 |
| Initiation | HTFL | Piper Sandler | -- | Overweight | -- | $38 | Sept. 2, 2025 |
| Initiation | HTFL | Stifel | -- | Buy | -- | $35 | Sept. 2, 2025 |
News
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
HTFL
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Read More
Medtech firm Heartflow gains 47% in solid Nasdaq debut
HTFL
Published: August 08, 2025 by: Reuters
Sentiment: Positive
Published: August 08, 2025 by: Reuters
Sentiment: Positive
Shares of Heartflow rose nearly 47.4% in their Nasdaq debut on Friday, valuing the medical technology company at $2.27 billion.
Read More
About Heartflow, Inc. Common Stock (HTFL)
- IPO Date 2025-08-07
- Website https://www.heartflow.com
- Industry Medical - Healthcare Information Services
- CEO John Farquhar
- Employees 626
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.